Epilepsies Partial

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-07-22
EMA Authorised: Zonegran (zonisamide) — Amdipharm Limited
EMA authorises Zonegran (zonisamide) by Amdipharm Limited for partial epilepsies in Europe.